The Latest Breaking News from Johnson & Johnson (

With solid Q2 results and 2025 guidance increases, Wall Street is upgrading these four stocks. Analysts now see palpable upside in one streaming stalwart.

Ever feel like you’re making diverse choices at the grocery store or pharmacy? In reality, many of the brands you think are competitors are actually owned by the same parent company. These corporate giants dominate entire industries, using multiple brand identities to give the illusion of variety. Once you understand…

U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78. The Nasdaq added 0.25% to finish at 20,730.49, while the SP 500 advanced 0.3% to 6,263.70.

Johnson & Johnson is back in rally mode after years of post-pandemic normalization and the impact of repositioning, set up to sustain higher prices for years.

U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Wednesday.

Johnson Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68.

Asian shares are trading mostly lower as worries about President Donald Trump’s latest updates to his tariffs weighed on investor sentiments

A rotation back into value stocks may be imminent in today's market, giving investors a chance to expose themselves into a catch up play.

Hair care should make you look better, not worse. Yet several major shampoo brands are now facing serious legal challenges from consumers who claim these products caused hair loss, scalp irritation, and other injuries. These lawsuits highlight growing concerns about potentially harmful ingredients in everyday hair care products.